InMode (INMD) Free Cash Flow Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -1.82% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 226.77% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 9.73% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -51.69% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -109.40% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 133.09% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 363.84% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 108.16% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 29.12% |
| 10 | InMode | 3.41 | -384.57 Mn | 61.55 Mn | 10.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.11% |
| Dec 31, 2025 | -28.98% |
| Sep 30, 2025 | -27.91% |
| Jun 30, 2025 | -42.58% |
| Mar 31, 2025 | -41.68% |
| Dec 31, 2024 | -46.60% |
| Sep 30, 2024 | -17.95% |
| Jun 30, 2024 | -20.47% |
| Mar 31, 2024 | 12.92% |
| Dec 31, 2023 | 6.45% |
| Sep 30, 2023 | -9.54% |
| Jun 30, 2023 | 11.89% |
| Mar 31, 2023 | -33.27% |
| Dec 31, 2022 | 8.30% |
| Sep 30, 2022 | -9.36% |
| Jun 30, 2022 | 0.96% |
| Mar 31, 2022 | 28.96% |
| Dec 31, 2021 | 27.52% |
| Sep 30, 2021 | 67.43% |
| Jun 30, 2021 | 2,938.13% |
| Mar 31, 2021 | 300.88% |
| Dec 31, 2020 | 50.84% |
| Sep 30, 2020 | 123.28% |
| Jun 30, 2020 | -91.66% |
| Mar 31, 2020 | 97.49% |
| Dec 31, 2019 | 188.97% |
| Sep 30, 2019 | 85.67% |
| Jun 30, 2019 | 43.33% |